Sanofi is a French pharmaceutical company, formerly known as Sanofi-Aventis. It is one of the world's leading pharmaceutical corporations. It operates in more than one hundred countries. The company's headquarters is located in Paris. One of the most famous Sanofi products in Russia is Essentiale, Amaril, No-Spa, Festal, Lasolvan.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential
Sanofi news
27.10.2023
Sanofi's IFRS net profit for 9 months of 2023 amounted to €5.994 billion, up 12.8% from €5.316 billion in the previous year. Revenue declined 0.4% to €32.151 billion from €32.272 billion a year earlier.
Source: 
sanofi.com
sanofi.com
28.07.2023
Sanofi's IFRS net profit for 6 months of 2023 amounted to €3.456 billion, up 6.8% from €3.237 billion in the previous year. Revenue rose 2% to €20.187 billion from €19.79 billion a year earlier.
Source: 
ml-eu.globenewswire.com
ml-eu.globenewswire.com
27.04.2023
Sanofi's IFRS net profit for 3 months of 2023 was €2.009 billion, down 0.4% from €2.017 billion in the previous year. Revenue increased by 5.7% to €10.222 billion compared to €9.674 billion a year earlier.
Source: ml-eu.globenewswire.com
ml-eu.globenewswire.com
13.03.2023
Sanofi is buying U.S. pharmaceutical company Provention Bio for $2.9 billion, or $25 per share. Company is the developer of TZIELD, the only drug approved in the U.S. to slow the onset of Stage 3 Type 1 diabetes. Closing of deal is scheduled for the second quarter of 2023.
Source: sanofi.com
sanofi.com
General information
| Company name | Sanofi |
|---|---|
| Tags | #pharmacy |
| Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals |
| Business address | 54 RUE LA BOETIE PARIS I0 75008 33153774400 |
| Mailing address | 54 RUE LA BOETIE PARIS I0 75008 |
| Website | www.sanofi.com |
| Information disclosure | www.sec.gov |
English (US) 